Clinical Trial Update: Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Binodenoson in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Binodenoson (binodenoson)

Snippet

Sponsor: Pfizer | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED